33 related articles for article (PubMed ID: 24760832)
1. LipL32 is an extracellular matrix-interacting protein of Leptospira spp. and Pseudoalteromonas tunicata.
Hoke DE; Egan S; Cullen PA; Adler B
Infect Immun; 2008 May; 76(5):2063-9. PubMed ID: 18285490
[TBL] [Abstract][Full Text] [Related]
2. Active Components of Leptospira Outer Membrane Protein LipL32 to Toll-Like Receptor 2.
Hsu SH; Hung CC; Chang MY; Ko YC; Yang HY; Hsu HH; Tian YC; Chou LF; Pan RL; Tseng FG; Yang CW
Sci Rep; 2017 Aug; 7(1):8363. PubMed ID: 28827637
[TBL] [Abstract][Full Text] [Related]
3. Blocking pathogenic Leptospira invasion with aptamer molecules targeting outer membrane LipL32 protein.
Hsu SH; Yang HY; Chang CC; Tsai SK; Li C; Chang MY; Ko YC; Chou LF; Tsai CY; Tian YC; Yang CW
Microbes Infect; 2024; 26(4):105299. PubMed ID: 38224944
[TBL] [Abstract][Full Text] [Related]
4. Crystallization and preliminary X-ray analysis of LipL32 from Leptospira interrogans serovar Copenhageni.
Hauk P; Guzzo CR; Ho PL; Farah CS
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Mar; 65(Pt 3):307-9. PubMed ID: 19255491
[TBL] [Abstract][Full Text] [Related]
5. Calcium binding to leptospira outer membrane antigen LipL32 is not necessary for its interaction with plasma fibronectin, collagen type IV, and plasminogen.
Hauk P; Barbosa AS; Ho PL; Farah CS
J Biol Chem; 2012 Feb; 287(7):4826-34. PubMed ID: 22147698
[TBL] [Abstract][Full Text] [Related]
6. Current immunological and molecular tools for leptospirosis: diagnostics, vaccine design, and biomarkers for predicting severity.
Rajapakse S; Rodrigo C; Handunnetti SM; Fernando SD
Ann Clin Microbiol Antimicrob; 2015 Jan; 14():2. PubMed ID: 25591623
[TBL] [Abstract][Full Text] [Related]
7. Development of an immunochromatographic test with anti-LipL32-coupled gold nanoparticles for Leptospira detection.
Chirathaworn C; Janwitthayanan W; Sereemaspun A; Lertpocasombat K; Rungpanich U; Ekpo P; Suwancharoen D
New Microbiol; 2014 Apr; 37(2):201-7. PubMed ID: 24858647
[TBL] [Abstract][Full Text] [Related]
8. Leptospirosis in humans.
Haake DA; Levett PN
Curr Top Microbiol Immunol; 2015; 387():65-97. PubMed ID: 25388133
[TBL] [Abstract][Full Text] [Related]
9. The molecular basis of leptospiral pathogenesis.
Murray GL
Curr Top Microbiol Immunol; 2015; 387():139-85. PubMed ID: 25388135
[TBL] [Abstract][Full Text] [Related]
10. A New Recombinant Multiepitope Chimeric Protein of
Fernandes LGV; Avelar KES; Romero EC; Heinemann MB; Kirchgatter K; Nascimento ALTO
Trop Med Infect Dis; 2022 Nov; 7(11):. PubMed ID: 36355904
[TBL] [Abstract][Full Text] [Related]
11. The leptospiral LipL21 and LipL41 proteins exhibit a broad spectrum of interactions with host cell components.
Takahashi ; Teixeira ; Nascimento
Virulence; 2021 Dec; 12(1):2798-2813. PubMed ID: 34719356
[TBL] [Abstract][Full Text] [Related]
12. Oral immunization of rat with chromosomal expression LipL32 in attenuated
Samakchan N; Thinwang P; Boonyom R
Clin Exp Vaccine Res; 2021 Sep; 10(3):217-228. PubMed ID: 34703804
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of truncated LipL32 expressed by Escherichia coli and Pichia pastoris for serodiagnosis of Leptospira infection in rodents.
Shiokawa K; Gamage CD; Koizumi N; Sakoda Y; Shimizu K; Tsuda Y; Yoshimatsu K; Arikawa J
J Vet Med Sci; 2016 Feb; 78(2):221-30. PubMed ID: 26412049
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic epitopes of Leptospira LipL32 protein and their characteristics.
Maneewatch S; Adisakwattana P; Chaisri U; Saengjaruk P; Srimanote P; Thanongsaksrikul J; Sakolvaree Y; Poungpan P; Chaicumpa W
Protein Eng Des Sel; 2014 May; 27(5):135-44. PubMed ID: 24760832
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies to LipL32 protect against heterologous Leptospira spp. challenge.
Maneewatch S; Sakolvaree Y; Saengjaruk P; Srimanote P; Tapchaisri P; Tongtawe P; Klaysing B; Wongratanacheewin S; Chongsa-Nguan M; Chaicumpa W
Hybridoma (Larchmt); 2008 Dec; 27(6):453-65. PubMed ID: 19108618
[TBL] [Abstract][Full Text] [Related]
16. Immunodominance of LipL32
Pissawong T; Maneewatchararangsri S; Ritthisunthorn N; Soonthornworasiri N; Reamtong O; Adisakwattana P; Kalambaheti T; Chaisri U; Doungchawee G
J Microbiol Immunol Infect; 2020 Feb; 53(1):11-22. PubMed ID: 29500044
[TBL] [Abstract][Full Text] [Related]
17. Molecular modeling and in-silico engineering of Cardamom mosaic virus coat protein for the presentation of immunogenic epitopes of Leptospira LipL32.
Kumar V; Damodharan S; Pandaranayaka EP; Madathiparambil MG; Tennyson J
J Biomol Struct Dyn; 2016; 34(1):42-56. PubMed ID: 25692534
[TBL] [Abstract][Full Text] [Related]
18. The lipoprotein LipL32, an enigma of leptospiral biology.
Murray GL
Vet Microbiol; 2013 Mar; 162(2-4):305-314. PubMed ID: 23206414
[TBL] [Abstract][Full Text] [Related]
19. Immunologic approaches to lipoprotein structure.
Schonfeld G; Krul ES
J Lipid Res; 1986 Jun; 27(6):583-601. PubMed ID: 2427630
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
